During the past decade, Covance Clinical Research Unit Ltd. conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 6 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Unit Ltd." #1 sponsor was "LEO Pharma" with 9 trials, followed by "H. Lundbeck A/S" with 7 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Xention Ltd" with 4 trials sponsored and "AnaMar AB" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit Ltd." #1 collaborator was "Covance" with 12 trials as a collaborator, "Medical Research Council" with 2 trials as a collaborator, "Foundation for Therapeutic Research, Lausanne" with 1 trials as a collaborator, "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator and "Insud Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit Ltd." are "Healthy" (18 trials), "Healthy Volunteers" (8 trials), "Healthy Subjects" (3 trials), "Psoriasis Vulgaris" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Covance Clinical Research Unit Ltd." in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Unit Ltd." are "Drug" (58 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "TA-8995" (4 trials), "Lu AF35700" (3 trials), "Midazolam" (3 trials) and "Digoxin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Unit Ltd." are 38 trials for "All" genders and 22 trials for "Male" genders.

Currently, there are NaN active trials in "Covance Clinical Research Unit Ltd.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Covance Clinical Research Unit Ltd., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Unit Ltd., 58 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".